Skip to contentM
Medifast Inc
M
MEDMedifast Inc Q2 2021 · 10-Q
Revenue$394.19M$394.19M+79.2% vs Q2 2020 Net Income$46.96M$46.96M+114.1% vs Q2 2020 EPS Diluted$3.96$3.96+112.9% vs Q2 2020 Gross Profit$293,707,000+84.4% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Medifast Inc · CIK 910329 · Engraved from SEC EDGAR
Operating Cash Flowderived$20,878,000−63.7% Free Cash Flowderived$13,280,000−76.8% Margins · derivedGross margin74.5%+2.1 pt vs Q2 2020
Operating margin15.6%+2.8 pt vs Q2 2020
Net margin11.9%+1.9 pt vs Q2 2020
ended Jun 30, 2021 · filed Aug 4, 2021 · 35 d after period end